In Europe, AZ Vaccination Suspends One After Another… All or specific production (2 total reports)

(Seoul = Yonhap News) Reporter Lee Kwang-bin and Lee Young-seop = European countries that temporarily stop using some or all of the COVID-19 vaccine produced by the multinational pharmaceutical company AstraZeneca are appearing one after another.

This is a preventive measure after reports that blood clots have formed in some citizens who received the vaccine in Europe.

◇Stop vaccination at certain manufacturing units in Romania, Italy, Austria, etc.

According to a Reuters news agency on the 11th (local time), Romanian authorities temporarily suspended the vaccination of a batch of AstraZeneca Corona 19 (a novel coronavirus infection) vaccine.

This temporary suspension is a measure following a recent report of suspected side effects related to AstraZeneca vaccination in Italy and elsewhere, and is not directly related to the situation in Romania.

The Romanian National Vaccine Committee explained that it was “a decision made with extreme precautions” and “based on cases reported in Italy.”

The manufacturing unit of the vaccine for which vaccination was discontinued is’ABV2856′, as in Italy earlier this day.

The Italian Medicines Agency (AIFA) has decided to temporarily suspend vaccination at this manufacturing unit nationwide. AIFA explained that it had made a prophylactic decision regarding the recently reported suspected serious adverse events.

Italian media reported that it was due to two deaths in Sicily following the vaccination, but AIFA said that a causal relationship between these deaths and vaccination has not been confirmed to date.

Romanian authorities have said that other manufacturing units have been vaccinated against AstraZeneca.

Romania received 81,600 doses of vaccine from the manufacturing unit that was discontinued at the beginning of February, and has used 77,000 doses so far.

Romania plans to keep the suspension until the European Medicines Agency (EMA) has completed the relevant investigation.

Earlier, Austrian authorities also stopped vaccinating the manufacturing unit vaccine after a 49-year-old woman recently died of’severe coagulation disorder’ after vaccination with AstraZeneca.

Austrian authorities said there was no evidence of a link between mortality and vaccination, but as a precautionary measure it would not inoculate the remaining quantities of the manufacturing unit.

As a result, four countries, including Estonia, Latvia, Lithuania, and Luxembourg, have stopped vaccinating the problem of manufacturing units in Austria.

The vaccine manufacturing unit that Austria stopped using was’ABV5300′, which supplied 1 million doses to 17 European countries.

◇ Even countries that have stopped vaccination of the entire AZ vaccine… EMA “No evidence of clot causality”

Some European countries have stopped vaccinating the entire AstraZeneca vaccine.

Bulgarian Prime Minister Voyko Borisov said on the 12th, “AstraZeneca vaccination will be stopped until EMA has cleared all safety concerns,” AFP news agency said.

Previously, Denmark, Norway and Iceland also stopped getting the vaccine.

In Denmark, a 60-year-old woman died of a blood clot who received the same manufacturing unit product as the AstraZeneca vaccine used in Austria.

Local authorities said they had decided to stop vaccination for two weeks as a precautionary measure, even though they could not conclude the link between the vaccine and death.

Danish Health Minister Magnus Heunike of Denmark said on Twitter that “a thorough investigation is needed,” according to CNN.

According to Bloomberg News, 22 cases of thrombosis were reported out of the 3 million people who received the AstraZeneca vaccine in Europe as of the 9th.

To date, at least nine European countries have stopped vaccinating all or some manufacturing units of the AstraZeneca vaccine, the news agency said.

However, there are voices advocating the safety of the AstraZeneca vaccine, saying that there is no clear evidence of side effects in the same European part.

In a statement on the 11th, EMA repeated the day before that there were no indications that the current vaccination caused a blood clot-related disease.

The EMA explained that the benefits of the vaccine outweigh the risks and that the vaccine could continue to be given while investigations are underway for cases involving blood clots.

British authorities have advocated the safety of the AstraZeneca vaccine, and Sweden, France, Spain and the Netherlands have no problem so far.

German health authorities also defended the EMA’s position, saying that although 11 cases of blood clots were reported in their country after vaccination, the causal relationship between vaccination and blood clots was not proven.

Outside of Europe, some countries have mixed positions regarding the safety of the AstraZeneca vaccine.

Thailand’s Vice Minister of Health Kiattiphum Wongchit said at a press conference on the 12th that the AstraZeneca vaccination was temporarily delayed due to safety concerns.

Meanwhile, Australian Prime Minister Scott Morrison said he would not stop vaccinating AstraZeneca. He said health authorities have not raised concerns and will continue to monitor progress outside the country.

[email protected]

Unauthorized reproduction-redistribution prohibited>
2021/03/12 20:48 sent